ADAPTIVE BIOTECHNOLOGIES COR

About

Adaptive Biotechnologies Corporation operates as a commercial-stage biotechnology company focused on harnessing the adaptive immune system to transform the diagnosis and treatment of disease. The company utilizes a proprietary immune medicine platform to profile T-cell and B-cell receptors, developing clinical products for therapeutic and diagnostic applications, particularly in immune-mediated diseases and oncology. By translating the genetic code of the immune system into clinical insights, Adaptive aims to enable precision medicine and improve patient outcomes.